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Abstract 
Tumorigenesis is a complex process involving numerous cellular signaling 
cascades and environmental factors. Here, we report the fabrication of 3D 
scaffolds with different morphologies obtained by to study cancer cell proliferation 
and migration. Using an FDA approved, biocompatible and biodegradable polymer 
Polycaprolactone (PCL), we electrospun nanofiber scaffolds having mesh, aligned, 
and honeycomb morphologies. The role of the morphology and cellular 
preferences to nutrition in cell adhesion and proliferation was assessed using 
scaffolds obtained by electrospinning PCL with fluorescent fructose-like molecular 
probes. Cell viability, cell morphology, localized cellular growth as related to 
scaffold morphology and availability of the fructose-like molecular probes were 
investigated. The changes in biophysical properties of tumor microenvironment 
with change in morphology of the scaffolds were observed. In vitro tests for 
proliferation, alignment and migration of human dermal fibroblasts (HDFa), normal 
breast epithelial cells (184B5), adenocarcinoma (MCF-7), pre-malignant 
(MCF10AneoT) and triple-negative (MDA-MB-231 on the scaffolds on days 1, 2, 
and 3 were carried out. The morphology of the scaffolds was characterized using 
FE-SEM while surface characterization was done using FTIR. Mechanical 
properties of the scaffolds were investigated using a Dynamic Mechanical Analyzer 
(DMA). Cell proliferation was assessed using CellTiter-Blue® Viability Assay; 
migration and cell-scaffold interactions were investigated using phalloidin for F-
Actin. Our data indicates that while topographical features affected cell adhesion 
and proliferation, cell lines that responded to the fructose-like probes tended to be 
more invasive. Furthermore, the preference to a specific scaffold was greatly 
altered by the presence of the probes with MDA-MB-231 showing least preference 
after 72 hours and pre-malignant MCF10AneoT showing highest preference. 
However, there was no significant difference in the cell numbers between scaffolds 
with probes and those without for the pre-malignant cells while this difference was 
noticeable in the control cell lines. Hence, a relation between cell preferences, 





The Surveillance, Epidemiology and End Results Program (SEER) estimates 
about 1.8 million people will be diagnosed with cancer in the United States in 2019 
alone [1]. It is also predicted that nearly 50% of these people will be diagnosed 
with breast, lung and bronchus, prostate, or colorectal cancers and that these four 
cancers will be responsible for roughly 50% of all cancer deaths in 2019 [2]. An 
estimated 270,000 men and women will be diagnosed with breast cancer in 2019. 
Approximately 12.8 percent of women will be diagnosed with female breast cancer 
at some point during their lifetime making it the most common cancer diagnosis in 
the US. Fortunately, in its early stages breast cancer is fairly treatable, however in 
later stages, after metastasis to distant tissues, the survival rate is only 27.4% 
making it an important area of study [3]. The average cost of treatment is between 
$20.000 and $100,000 depending on the severity [4] and anywhere from 5 to 10 
years of hormone therapy after chemotherapy, radiation or surgery, sometimes all 
three [5]. 
1.2 Defining Cancer 
Cancer is defined as a disease which manifests due to mutations in one or 
more genes causing uncontrolled cell growth and leading to the formation of a 
tumorous mass [6, 7]. The progression, size and location of the tumor defines the 
stage of cancer. Stage 0 is typically thought of as cancer free but abnormal cells 
with the potential to become cancerous have been found. This is sometimes 
referred to as carcinoma in situ cells present in this stage are called premalignant. 
Stage I indicates cancer exists in only a small area, this is usually considered early 
stage and tumors present are called primary tumors. Larger cancer which has 
grown into nearby tissues or lymph nodes are classified as stage II or III. Once the 
cancer has spread to distant parts of the body it is considered to have metastasized 
and is referred to as advanced or stage IV resulting in the presence of metastatic 
cells such as adenocarcinomas [8].  
1.3 Current Treatment  
Depending on the stage, different treatment options are available for patients. 
The National Breast Cancer Foundation offers the following summary of treatment 
options for different stages of breast cancer: In the case of a primary tumor, surgery 
is usually suggested in order to remove the tumor with a lumpectomy, partial 
mastectomy, or radical mastectomy. If it’s deemed necessary, some oncologists 
may also prescribe localized radiation and hormone therapy to ensure all 
dangerous cells are eradicated. Treatment options vary widely for stage II and III 
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cancers consisting of mastectomy, localized radiation, hormone therapy, 
chemotherapy, or in the most successful cases a combination of two or more 
treatments. Stage IV indicates the cancer has spread to distant tissues such as 
the brain bones, liver and lungs this stage is considered incurable however it has 
been shown to respond to a number of treatment options which could extend a 
patient’s life several years [9].  
1.4 Biology of Cancer 
Unfortunately, because every patient is different, there is no one size fits all 
treatment option and in too many cases time, money, and resources are spent in 
identifying treatment options and may have severe side effects and ultimately may 
not work. Investigations into the inner workings of this disease could offer 
additional information for combating it. Numerous studies have shown differential 
characteristics when comparing the tumor microenvironment to a healthy 
physiological microenvironment [10]. Most notably, the tumor microenvironment is 
more acidic exhibiting a pH of around 6.8 compared to the more basic physiological 
pH of 7.4 [11]. This has been theorized to be due to the hypoxic, or deoxygenated 
conditions within a tumor which leads to anaerobic metabolism resulting in 
increased levels of acetic acid. The tumor microenvironment is also stiffer than the 
surrounding tissues and cancer cells typically have less stiff cellular membrane. 
1.5 Our Approach 
Since anaerobic metabolism doesn’t yield the same amount of ATP as the 
Kreb’s cycle, cancer cells have adapted and shortened the process by taking up 
fructose in addition to glucose to obtain a sufficient amount of energy for growth, 
proliferation, and metastasis. Fructose is transported to the cells via facilitative 
transporters, specifically GLUT5 (SLC2A5). This transporter has not been reported 
to be as active in non-cancerous cells [12]. The Warburg effect determined this 
affinity to anaerobic metabolism is present even in oxygenated conditions [13] 
making exploitation of the GLUT5 pathway using fructose an area of interest.  
To examine the behavior of cancer cells and identify better treatment 
options in vitro models of the tumor microenvironment have been used. These 
models provide a low-cost research platform for cancer therapies, drug screening 
and insight on the mechanisms of metastasis by studying the cells in within the 
tumor, its stroma, extracellular matrix (ECM) and surrounding signaling molecules.  
Current in vitro models such as transwell-based assays monitor cancer cell 
migration in response to some stimuli or condition such as chemo attractants, drug 
treatments or gene manipulation [14, 15]. These models, although useful with 
regards to cancer cell migration and invasion, don’t offer a dynamic environment 
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such as that of the tumor microenvironment as the conditions are limited to single 
cell migration, invasion and trans endothelial migration in two dimensions.  
Spheroids on the other hand are cell aggregates grown in suspension which 
closely resemble the spherical nature of a tumor. This makes them more useful for 
drug screening, studying immune interactions, and studying tumor growth and 
proliferation when compared to 2D cell culture. Sometimes spheroids are grown 
embedded in matrix and allows for studies of invasion, matrix remodeling and 
angiogenesis. Spheroids embedded in a matrix recapitulate transport properties 
cell-cell and cell-matrix interactions between the cells and the tumor 
microenvironment [16-18]. Due to their shape larger spheroids sustain oxygen and 
nutrient gradients which bear result in the emergence of a necrotic core which bare 
similarities to poorly vascularized physiological tumors [19]. Proliferation gradients 
have also been demonstrated in spheroid models resulting in protein and gene 
expression profiles more closely resembling those of clinical and in vivo gene 
expression profiles when compared to 2D culture [20]. These models are more 
costly and time consuming when compared to transwell assays. Spheroids also 
pose challenges to maintain uniformity and in the case of suspended spheroids 
don’t account for the biophysical cues from the ECM.  
I hypothesize nanofiber scaffolds composed of FDA approved 
biodegradable, biocompatible polymers and designed to offer controllable 
biophysical cues would provide a more physiologically accurate in vitro tumor 
model than transwell assays or spheroids. I further hypothesize the biochemical 
cues present in the tumor microenvironment can be imitated by incorporating 
signaling molecules into the scaffolds. The incorporation of fluorescent fructose 
probes is expected to offer insight into the metabolism of several cell lines on PCL 
nanofiber scaffolds of different topographical morphologies, affecting topotaxis and 
durotaxis. We also hope to investigate potential behavior of integrated drugs into 




2 Materials and Methods 
2.1 Fiber Fabrication 
2.1.1 Solution Preparation 
All polymer solutions dissolved in chloroform were properly labeled and 
stirred on a hotplate protected from light at 32°C and 640 RPM (Fisherbrand™ 
Isotemp™ Stirring Hotplate) to reduce oxidation due to light exposure and prevent 
production of phosgene. 
2.1.1.1 Polycaprolactone 
Polycaprolactone (PCL) is an FDA approved, biodegradable polyester 
which has gained a lot of attention for its controllable mechanical properties and 
slow degradation rates. Its physiochemical state, chemical and biological 
properties, degradability and mechanical strength can all be adjusted allowing it to 
be used under harsh mechanical, physical and chemical conditions without 
significant loss of its properties. 
A solution consisting of 20% PCL (Mw = 70,000 GPC; Scientific Polymer 
Products, USA) was prepared in Chloroform HPLC Grade (Sigma Aldrich, USA). 
The solution was heated and mixed away from light at 32°C and 640 RPM 
(Fisherbrand™ Isotemp™ Stirring Hotplate) until homogeneous.  
2.1.1.2 ManCou-H Synthesis 
The affinity of breast cancer cells to fructose allowed for the investigation of 
their metabolic preferences using fluorescent fructose-like molecules as probes. 
The biomedical microdevices lab partnered with Dr. Tanasova’s team in the 
chemistry department at Michigan Technological University to test the fructose-like 
molecular probe ManCou-H [21-24]. ManCou-H is composed of mannitol with a 
coumarin as a fluorescent tag with a hydrogen located in the C4 position.   
D-Glucosamine hydrochloride (4.0g, 18.6 mmol, 1.0eq) was dissolved in 
water (40 ml) and stirred at room temperature for 5 hours.  The solution was then 
cooled down with an ice bath. Once cooled, sodium nitrite (3.2g, 46.5 mmol, 2.5eq) 
was added followed by portion wise addition of Amberlite 120 H+ (acidic) resin (30 
mL). The reaction was then left to stir overnight at 0-4° C. The acidic resin was 
then filtration off and the reaction mixture was neutralized with Amberlite IRA-400 
basic resin.  The solution was then filtered, and the filtrate was dried via 
lyophilization to remove water. The desired compound was obtained as a yellow 
sicky solid in 79% yield (2.4 g) and was further used without purification (figure 
2.1). 
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Figure 2.1 Synthesis of Mannitol using D-Glucosamine HCI the addition of water and 
sodium nitrate. 
 
Aldehyde 2 (162.0 mg, 1.0 mmol, 1.0 eq) and 7-aminocoumarin (161.0mg, 
1.0 mmol, 1.0 eq) were place into the round bottom flask and dissolved in 
MeOH/AcOH solution (10 ml, 95:5 v/v).  The reaction mixture was allowed to stir 
at room temperature for 30 min. NaBH3CN (3.0 eq) was then added portion wise 
(3 x 1.0 mmol) every 30 min and the reaction was allowed to stir at room 
temperature overnight (8-10 h).  The mixture was then concentrated to dryness 
under reduced pressure and subjected to column chromatography. The desired 
product was eluted using CH2Cl2: MeOH mixture (9:1 v/v). Samples for biological 
testing were further purified on a semi-preparative HPLC using a water-
acetonitrile (5->30%) gradient (figure 2.2). The completed molecule with labeled 
sections is shown in figure 2.3. 
 
Figure 2.2 Synthesis of Mannitol to Coumarin in order to yield ManCou with a hydrogen 
in the functional C4 position. 
Yellow solid, 169 mg, 55% yield.  1H NMR (400 MHz, CD3OD): δ, 7.76-7.36 
(d, J = 9.2, 1H), 7.32-7.30 (d, J = 8.4, 1H), 6.68-6.65 (dd, J1 = 2.4, J2 = 8.4, 1H), 
6.53 (d, J = 2.4, 1H), 6.01-5.99 (d, J = 9.2, 1H), 4.02-3.98 (m, 2H), 3.95-3.92 (m, 
1H), 3.88-3.85 (m, 1H), 3.73-3.69 (dd, J1 = 3.2, J2 = 12.0, 1H), 3.66-3.61 (dd, J1 = 
5.6, J2 = 12.0, 1H), 3.48-3.44 (dd, J1 = 3.6, J2 = 13.6, 1H), 3.38-3.32 (dd, J1 = 6.8, 
J2 = 13.6, 1H) ppm. 13C NMR (100 MHz, CD3OD): δ, 164.7, 158.1, 154.5, 146.5, 
6 
130.2, 112.3, 110.6, 109.1, 98.0, 85.3, 83.2, 80.3, 78.9, 63.3, 46.2 ppm. HRMS 
(ESI): m/z [M + Na] + calcd. 
 
Figure 2.3 Complete ManCou-H molecule with coumarin fluorescent component shown 
in blue and GLUT5 binding Mannitol component in the black. 
2.1.1.3 Polycaprolactone with ManCou-H 
To produce biochemically different samples a 20% PCL solution similar to 
that described in 2.1.1.2 was mixed with a 20 µM final concentration of ManCou-
H probe before being sonicated and degassed (Fisher Scientific™ CPXH Series 
Digital Ultrasonic Cleaners) for 30 min prior to electrospinning.  
2.1.2 Electrospinning 
Electrospinning exploits the electric field to draw charged threads of 
polymer solutions or polymer melts and continually produce fibers ranging from a 
few microns in diameter to ultrathin fibers in tens of nanometers. The 
electrospinning process is versatile, and flexible and has the potential to be scaled 
up for industrial production. This technique has been shown to have applications 
in tissue engineering for scaffold fabrication due to its ability to produce variable 
7 
fibrous scaffolds repeatedly, including topographies mimicking mesh, aligned and 
honeycomb structures similar to those of the natural ECM in the body. 
The environmental factors like humidity and temperature, and tip-nozzle 
distance and as well as needle diameter were maintained at a constant throughout 
the electrospinning process (EM-DIG and EM-RTC; IME Technologies, 
Netherlands). These constants were 16% humidity, 70 °F, 17 cm and 0.6 mm, 
respectively. The parameters for all morphologies were held constant regardless 
of the presence of ManCou-H probe. For the fabrication of scaffolds with mesh 
morphologies, a voltage of 11 kV and rotational velocity of 150 RPM with polymer 
flow rate of 0.24 mL/hr was used whereas for scaffolds with aligned morphologies, 
a similar polymer flow rate and voltage was used with increased rotational speed 
of 275 RPM. The honeycomb structured scaffolds were fabricated by 
electrospinning at a rotational speed of 300 RPM with a feed rate of 0.18 mL/hr 
and applied voltage at the tip of the needle at 10 kV.  
2.2 Fiber Characterization 
2.2.1 Field Emission Scanning Electron Microscopy (FE-SEM) 
Rather than using photons, Field Emission Scanning Electron Microscopy 
(FE-SEM) uses electrons liberated from a tungsten field emission source allowing 
for visualization of nanometer sized features. Once liberated, these electrons are 
accelerated in a high electrical field gradient which produces an ultralow vacuum 
environment. Electrons are then focused onto the samples of interest using 
electromagnetic lenses and apertures within the column to control the beam. 
Images are obtained by collecting electrons scattered by the object under 
interrogation on a fluorescent screen or cathode-ray tube (CRT). FE-SEM is 
capable of obtaining both backscatter and secondary electron images of 
conductive samples and can also be used for energy dispersive spectroscopy 
(EDS) for chemical microanalysis. Non-conductive samples must first be sputter 
coated with a thin layer of conductive metals most commonly carbon, gold, or 
platinum/palladium (Pt/Pd).  
FE-SEM is a surface technique which allows for clear and accurate 
visualization of nanoscale features making it useful for polymer nanofiber 
visualization. To image the topographical morphology of the PCL fibers they were 
sputter coated with 5 nm of Pt/Pd. The fibers were then viewed while fixed to pin 
stub specimen mounts with carbon tape using an accelerating voltage of 10 kV. 
Various magnifications were used to obtain points of interest and the FESEM 
(Hitachi S-4700 FE-SEM). Greyscale images were captured and processed using 
ImageJ™ to measure the diameter of the nanofibers as well as their directionality 
using the ruler and Directionality™ plugin, respectively [25, 26].  
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2.2.2 Fourier Transform Infrared Spectroscopy (FTIR) 
FTIR or Fourier Transform Infrared Spectroscopy is used to obtain an 
infrared spectrum of absorption or emission of a material in solid, liquid or gaseous 
state. When infrared light is radiated onto the polymer samples it is absorbed only 
when the energy is equal to one of the transitions among the discrete energy levels 
of the molecule. 
The infrared spectroscopy of the scaffolds was characterized using 
Attenuated Fourier Transform Infrared Spectroscopy (Thermo Scientific™, 
Nicolet™ iS50 FTIR Spectrometer) from 4000–400 cm-1 at a resolution of 4 cm-1 
with 256 scans. 
2.2.3 Dynamic Mechanical Analysis (DMA) 
Dynamic Mechanical Analysis (DMA) is an instrument which uses a specific 
destructive testing technique to measure the physical properties of solids and 
polymer melts. It then reports the modulus and damping, and can be programmed 
to measure force, stress, strain, frequency and temperature. To use a sample of 
known dimensions is loaded onto the clamp holder apparatus, a load is applied, 
and the strain is measured. Load displacement can be controlled either by applying 
sinusoidal stress and measuring the strain or the load can be increased gradually 
to the point of fracture.  
The mechanical properties of each scaffold were measured by varying 
displacement with respect to time and obtaining stress until failure. The samples 
tested measured 0.75 cm in width, the length of each sample was measured by 
the DMA and the depth by a screw gauge. Each sample was then exposed to a 
stress and the strain was measured while the temperature was held constant at 
37°C. Collected data was graphed and analyzed in Origin Pro™ (n=3).  
2.2.4 Degradation 
The slow degradation of PCL is a major contributing factor for its popularity 
in the field of biomaterials. The long degradation rate has led to PCL being used 
primarily in the replacement of hard tissues where healing takes longer. However, 
it can be extended to engineered soft tissues by decreasing its molecular weight 
and degradation time.  
Scaffolds with and without ManCou-H probe of each morphology with side 
1cm (n = 3) were cut and placed in Phosphate Buffer Solution (PBS) at 37°C. At 
time points 1, 2 and 3 hours the PBS was removed and saved at 4°C before being 
replaced by new PBS and placed back in the incubator. These samples were then 
run through a plate reader (Beckman Coulter DTX 880 Multimode Detector) at 360 
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nm excitation and 425 nm emission and concentration of probe leached was 
estimated. 
2.3 Cell Seeding Experiments  
2.3.1 Cell Culture 
Adult human dermal fibroblasts (HDFa/ATCC® PCS-201-012™), 
adenocarcinoma (MCF7/ATCC® HTB-22™), triple negative malignant cells (MDA-
MB-231 / ATCC® HTB-26™) and human breast epithelium (184B5 / ATCC® CRL-
8799™) were purchased from America Type Cell Culture. The premalignant 
cancer cell line, MCF-10A-NeoT, was acquired from the Animal Model and 
Therapeutics Evaluation Core (AMTEC), Karmanos Cancer Institute, Wayne State 
University. Every cell line was maintained at 37°C, at 65% relative humidity, 5% 
CO2. All cell lines except MCF-10A-NeoT and 184B5 was maintained in RPMI 
1640 culture media supplemented with 10% fetal bovine serum (FBS) and 1% 
Penicillin Streptomycin (Pen Strep). MCF-10A-NeoT were cultured in DMEM F12 
Ham (1:1) from Gibco with 1.05 mM CaCl2, 10 mM HEPES, 10 µg/mL insulin, 20 
ng/mL EGF, 0.5 µg/mL hydrocortisone, 5% horse serum, and 100 ng/mL cholera 
toxin. 184B5 was maintained in MEBM supplemented with MEGM Lonza/Clonetics 
Corporation kit (Kit Catalog No. CC-3150) minus the GA-1000 (gentamycin-
amphotericin B mix).  
2.3.2 Cell Seeding 
Breast cell lines including, 184B5, MCF7, MCF-10A-NeoT, and MDA-MB-
231 were seeded on scaffolds at a density of 1500 cells per scaffold of side 0.5 cm 
for cell viability experiments and scaffolds with dimensions 1.0 x 0.5 cm2 for 
immunofluorescent imaging (n=3). The negative control, adult human dermal 
fibroblasts, HDFa were seeded at a concentration of 2500 cells per scaffold to 
account for the lower rate of proliferation (n=3). Cells were kept in their respective 
culture media on nanofiber scaffolds in non-treated tissue culture plates under 
standard cell culture conditions. As positive controls, 2500 HDFa cells per well and 
1500 cells per well for each of the breast cancer cell lines under test were cultured 
on standard tissue culture treated plates. 
2.4 Post-Cell Seeding Characterization 
2.4.1 Immunostaining 
Cells were fixed in 10 mL of 16% methanol-free formaldehyde solution 
diluted in 40 mL of PBS to produce a final concentration of 4% paraformaldehyde 
and visualized after 1, 2 and 3 days of growth via fluorescence microscopy. The 
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cells grown on ManCou-H integrated PCL fibers were stained with Alexa Fluor® 
594 Phalloidin (Invitrogen, USA) under TX red filter, with and excitation and 
emission of 596 nm and 615 nm, respectively,  as well as a DAPI filter, excitation 
and emission of 358 nm 461 nm, to illuminate the F-Actin within the cytoskeleton 
and the fluorescent fructose mimic, respectively. Cells grown on bare PCL fibers 
were also stained with Alexa Fluor® 594 Phalloidin (Invitrogen, USA) and imaged 
under the TX red filter but they were also stained with DAPI (4’,6-diamidino-2-
phenylindole) (Life Technologies, USA) for visualization of F-Actin and the A-T 
regions of the nucleus according to manufacturers’ protocol.  
2.4.2 Cell Alignment 
 Cell attachment and alignment along the fibers was quantified using image 
analysis software in MATLAB. The built in MATLAB functions for Otsu 
thresholding, and watershed were used to segment out the F-actin foreground of 
the immunostained images [27]. These segmented images were then run through 
another built in MATLAB function called ‘regionprops’ to be analyzed for their area 
and orientation [28, 29]. The standard deviation of the alignment orientation of 
each detected cell was then compared for each of the segmentation methods 
previously described. The average orientation deviation of these values was 
plotted using Microsoft Excel. 
2.4.3 Cell Viability 
The viability of the aforementioned cell lines on scaffolds with sides of 
approximately 0.5 cm (n=9) was obtained using CellTiter-Blue® Cell Viability 
Assay (Promega, Madison, WI). After 1, 2, and 3 days of growth in 48-wellplates 
(CellTreat scientific products®) the culture media was replaced and 20% volume 
of CellTiter-Blue® Cell Viability Assay reagent was added followed by 4 hours of 
incubation under standard culture conditions (37 °C, 65% RH and 5% CO2). A 
75µL aliquot of the incubated medium was transferred to a clear bottom 96-well 
opaque walled culture plate. Cell viability was determined using a plate reader 
(Beckman Coulter DTX 880 Multimode Detector) at 560 nm excitation and 590 nm 
emission.  
2.4.4 Statistical Analysis 
Statistical evaluation of the cell proliferation data was done using IBM® 
SPSS statistics V25 and OriginPro 2018b. Descriptive statistics was represented 
as mean ± standard error of mean (SEM) for cell viability and mean ± standard 
deviation (SD) for mechanical characterization of the scaffold. Fibers without 
ManCou-H probe were analyzed with one-way ANOVA followed by post-hoc 
Tukey’s HSD test to calculate significance at p<0.05 between different days for 
each morphology of the scaffold. The same method was used to calculate the 
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significance between different cell lines for each morphology of the scaffold. The 




3.1 Fiber Characterization 
By altering the electric field applied, the rotational velocity of the collecting 
mandrel, and the fluid flow rate during the electrospinning process three distinct 
topographical features were repeatably obtained using the same blend of 
polymeric materials. These three topographies are intended to imitate the natural 
ECM of various organs within the body. The applied electric field not only 
determines the initial elastic stress and bending instabilities in the jet [30], but it 
can also be used to control the spatial deposition of the fibers. This ability to control 
the spatial deposition is essential for creating topographical features [31]. The 
rotational velocity of the rotating mandrel collector helps better control the 
alignment, orientation and diameter of the fibers [32]. The applied electric field and 
rotational velocity work in conjunction as the applied average electric field 
determines the critical rotational velocity [33]. Typically, fibers exhibiting less 
alignment are produced using a lower rotational speed for the collector, 
alternatively, higher rotational speeds are used to fabricate scaffolds with fiber 
orientations perpendicular to the electric field vector. The flow rate at is typically a 
key parameter for controlling fiber diameter and distribution [34]. It initiates droplet 
shape, controls the trajectory of the jet, and maintains Taylor cone and deposition 
area [35, 36]. Higher flow rates result in higher fiber diameters and a higher 
deposition area whereas lower flow rates produce thinner fibers with a smaller 
deposition area.  
 
Figure 3.1 Field emission scanning electron microscopic (FESEM) images of the PCL 
scaffolds exhibiting different morphologies. The low magnification images (A, C, E) are 




























Visualization of the scaffolds was done using FE-SEM to analyze fiber 
morphology alignment, orientation, and diameter. Three distinct topographies with 
and without ManCou-H were initially visually classified as mesh, aligned, and 
honeycomb, shown in figure 4A, C and E, and figure 6A, C, and E, respectively. 
The lack of beading among all of the fiber scaffolds indicates an ideal concentration 
of PCL and chloroform solvent even in the case of fibers containing ManCou-H for 
electrospinning [37].  
 
Figure 3.2 The deviation in alignment of the fibers in different morphologies of the bare 
scaffolds was characterized using the directionality plugin in ImageJ from the FESEM 
images used in figure 3.1 (n=5). The mesh fibers had a high dispersion of fibers in differ 
different angles. The aligned fibers had a high concentration of fibers in a narrow angle 
range with little amount of deviation in other directions. The honeycomb scaffolds had a 
broader range of deviation compared to the aligned scaffold but a much narrower 
distribution than the mesh scaffolds. A comparison between the three morphologies helps 
to compare the amount of alignment of the fibers and deviation from alignment.  
The low magnification image of the mesh scaffolding without ManCou-H, 
(figure 3.1A) exhibited randomly oriented fibers which were densely packed 
forming a three-dimensional structure as seen by the cells. This dimensionality can 
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be seen from the change of contrast shown in the high magnification image shown 
in figure 3.1B which indicates the layers.  A similar trend can be seen in the 
ManCou-H containing fibers shown in figures 3.3A and 3.3B, for low and high 
magnification respectively. Upon further analysis using the directionality plugin by 
ImageJ these scaffolds exhibited the highest amount of deviation as compared to 
the other samples (figure 3.2A and 3.4A). The fiber diameter was determined to 
be uniform among the mesh scaffold of 169.7 nm ± 10.7 nm. 
Alternatively, the aligned scaffolds were found to have tightly packed fibers 
all oriented in the same direction. The deviation from alignment was calculated to 
be the lowest among the three morphologies (figure 3.2B and 3.4B). In the low 
magnification image (figure 3.3C) the fiber diameter appeared to show regions of 
larger and smaller diameter fibers in an alternating manner producing a channel 
like effect. The fiber diameter was determined to have a mean of 131.7 nm ± 21.77 
nm A high magnification image (figure 3.3D) of the region containing fibers with 
larger diameters showed high concentrations of aligned fibers which overlapped 
one another to form a tight network.  
 
Figure 3.3 Field emission scanning electron microscopic (FESEM) images of the ManCou-
H containing PCL scaffolds exhibiting different morphologies. The low magnification 
images (A, C, E) are present on the top while the high magnification images (B, D, F) are 
present in the bottom. 
The low magnification image of the bare and ManCou-H containing 
honeycomb scaffolds, shown in figure 3.1E and 3.3E, respectively, shows the 
formation of interwoven fibers which interlocked in a specific repeating pattern to 
produce elongated, asymmetrical, honeycomb like structures. The arrangement of 
the honeycomb structure was characterized to have deep pores which exhibited a 
long-range order. Figure 3.1F and 3.3F, the low magnification image of the 
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honeycomb structure, shows the boundary of the pores, revealing densely packed 
aligned fibers present at the bottom of the pores and densely packed aligned fibers 
along the walls. The orientation of these aligned fibers at the wall and the floor of 
the pores was different, because of this, when analyzing the orientation there was 
a high deviation in alignment more closely related to the mesh morphology than 
the aligned despite the densely packed aligned fibers (figure 3.2C and 3C). The 
fiber diameter was calculated to have a mean of 144.1 µm ± 47.4 µm According to 
a series of experiments done by Bauer and colleagues, the formation of the dense 
network helps to mimic the biophysical conditions present during tumor-induced 
angiogenesis [38, 39].  
 
Figure 3.4 The deviation in alignment of the fibers in different morphologies of the 
scaffolds was characterized using the directionality plugin in ImageJ from the FESEM 
images used in figure 3.3 (n=5). The mesh fibers had a high dispersion of fibers in different 
angles. The aligned fibers had a high concentration of fibers in a narrow angle range with 
little amount of deviation in other directions. The honeycomb scaffolds had a broader range 
of deviation compared to the aligned scaffold but a much narrower distribution than the 
mesh scaffolds. A comparison between the three morphologies helps to compare the 
amount of alignment of the fibers and deviation from alignment.     
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3.2 Chemical Composition 
Using ATR-FTIR spectroscopy, the surface characterization of the chemical 
bonds on the scaffolds in the absence and presence of ManCou-H was done 
shown in figure 3.1 and 3.3, respectively. The different morphologies inferred from 
FE-SEM and verified with image analysis using ImageJ showed similar 
absorbance intensities from the surface bonds which were extrapolated from 
infrared spectroscopy (figure 3.5A and 3.5B). This data cannot be used to draw a 
relationship between the isotropic nature of the fibers present in different scaffold 
morphologies because the incident beam was focused on a larger surface area 
rather than a single nanofiber. The peak seen at 1294 cm-1 is due to the stretching 
of C-O and C-C bonds in the crystalline phase [40]. As reported by Wang et. al the 
crystalline phase of PCL is accentuated during the electrospinning process[41]. 
This is due to the application of a high electric field causing the PCL chains to 
orient in a single direction [42]. The CH2 vibration and O-C vibrations occur at 732 
cm -1 and 961 cm -1 [43, 44], respectively while. bands seen at 1165 cm-1 and 1239 
cm-1 correspond to asymmetric and symmetric stretching of the ester COO group 
[45]. The peak at 1365 cm -1 is associated with the CH2 band vibrations [46]. The 
C=O vibration of ester corresponds to the peak present at 1723 cm-1 [47]. 
Asymmetric and symmetric stretching of the CH2 group are the cause of the peaks 
present at 2865 cm-1 and 2942 cm-1 [48, 49]. Wavenumber where peaks exist 
according to the ATR-FTIR can be seen in table 3.1.
 
Figure 3.5 The surface and mechanical characterization of the PCL scaffolds of different 
morphologies was done. A) and B) Surface characterization was done using ATR-FTIR 
spectroscopy on bare and probe containing fibers, respectively. The peaks distinctive to the 
to the molecular bond orientations present in PCL were identified. All the morphologies 
had similar surface chemistry.  
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Table 3.1 Wavenumber where peaks exist according to ATR - FTIR 
 
 
3.3 Mechanical Characterization 
Mechanical characterization of the scaffolds was done under isothermal 
conditions using DMA shown in figure 3.6. Each morphology demonstrated its own 
unique stress-strain behavior. The mechanical properties of the probe and non-
probe containing scaffolds are summarized in table 3.2. The honeycomb scaffolds 
exhibited the highest average ultimate strength, Young’s modulus, stiffness and 
strain at failure as compared to the other two morphologies. The Young’s modulus 
and stiffness of the aligned scaffolds was comparable to the honeycomb 
Wavenumber (cm-1) Significant Bonds
2942 cm-1 Asymmetric CH2 stretching
2865 cm-1 Symmetric CH2 stretching
1723 cm-1 C=O stretching of ester
1165 cm-1 C—O stretching
732 cm-1 CH2 vibration
1239 cm-1 Asymmetric C—O—C stretching
1365 cm-1 CH2 bending
961 cm-1 O–C vibrations
1046 cm-1 C—O—C stretching
1294 cm-1 C–O and C–C stretching in the crystalline 
phase
18 
structures; however, the modulus of toughness is lower than that of the honeycomb 
scaffolds. As compared to the honeycomb and aligned scaffolds the mesh fiber 
morphology has relatively poor strength and toughness. The honeycomb and 
aligned scaffolds are ductile while the mesh scaffolds behave more plastically. The 
low rotational velocity of the collector and voltage applied during the  fabrication 
process resulted in the mesh scaffolds elastomeric behavior [50]. Due to the 
fundamental truths of their morphology the aligned structures have better 
orientation in the microcrystalline regions which increases the Young’s modulus of 
the scaffold [51, 52].  
 
Figure 3.6 The mechanical properties of the scaffolds was characterized using DMA at 
isothermal conditions (37°C) and represented as stress-strain graph. 


























 The release of the fluorescent probe was quantified at time points 24, 48 
and 72 hours using a plate reader. These values were correlated to molarity of 
probe release on each day using a calibration curve (figure 3.7). A higher 
concentration of probe was shown to be released from the mesh scaffolds on day 
1 followed by the mesh and lastly the honeycomb structures. Day 2 showed a 
higher release from the mesh scaffolds followed by the aligned then the 
honeycomb. Day 3 followed the same trend. This trend is expected as honeycomb 
and aligned fibers have a higher surface area resulting in a smaller proportion of 
ManCou-H within the scaffold and limiting the available probe to be released. The 
estimated amount of probe released for each sample type can be seen in table 
3.3. Deviation in release could be the result of non-homogenous mixture of probe 
in PCL solution during the electrospinning process causing an uneven distribution 
of probe within the scaffold.  
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Figure 3.7 Observed drug released from PCL fibers in PBS  using ManCou-H probe over 
a 3 day period for each fiber morphology the honeycomb values appear to exist below the 
deflection limit. 
 
Table 3.3 Drug released from each fiber type measured in nanomolar 
 
3.5 Immunofluorescent Imaging 
Various stages of breast cancer progression were represented by using cell 































Day Mesh Aligned Honeycomb
1 66.98811 110.5206 -18.7537
2 93.92716 62.55685 -10.6373
3 38.3986 6.639262 -42.8728
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negative / metastatic to evaluate the topotactic behavior of breast cancer cells. 
Cells grown on nanofiber scaffolds were stained and fixed 1, 2, and 3 days after 
seeding. Cells grown on bare PCL scaffolds were stained for actin in red and 
nucleus in blue, however the ManCou-H containing scaffolds were only stained for 
actin in red and any blue is due to the ManCou-H probe. Prior to seeding and 
staining the scaffolds were tested for to determine whether or not they bound the 
stain. It was found that the scaffolds do not express any background absorption of 
primary or secondary antibodies indicating the fluorescence seen in the images 
are cells.  Had Alexa Fluor phalloidin 488 been used for actin staining NucRed™ 
could have been used to visualize the nucleus while still having the ability to 
differentiate the ManCou-H probe.  
To get a better idea of how each cell line spans the 1.0x0.5 cm2 scaffolds 
panoramas of the select cells on select scaffolds can be seen in figures 3.8 - 3.12. 
The adult human dermal fibroblasts can be seen in figure 3.8 on bare PCL 
scaffolds with a honeycomb morphology. Figure 3.9 shows the healthy breast 
epithelium on bare PCL scaffolds with a mesh morphology. Figure 3.10 shows 
MCF10ANeoT on aligned bare PCL scaffolds. Figure 3.11 shows MCF7 on bare 
honeycomb structured PCL scaffolds. Lastly the triple negative adenocarcinoma 
can be seen in figure 3.12 on aligned PCL fibers with the ManCou-H probe 
integrated into it. Qualitative classification for cell elongation, clumping, alignment 
to the scaffolds and infiltration within the scaffold are shown in figure 3.9. Phase 
images of fibers can be seen in Appendix A. In the future quantitative assessments 
of infiltration will be done using cryosectioning. This was attempted but a protocol 
for the cryosectioning of nanofibers is yet to be optimized.    
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Figure 3.8 A panorama of adult human dermal fibroblasts on bare PCL scaffolds with a 
honeycomb morphology. The nuclei were stained with DAPI shown in blue and the F-
actin filaments were stained with Alexa Fluor® 594 Phalloidin. The overlapping of the 
blue and red and dispersion by the fibers causes some of the cells to be seem pink in 
color. Images captured at 10X magnification.  
23 
 
Figure 3.9 A panorama of the healthy breast epithelial cell line, 184B5, on bare PCL fibers 
with a mesh morphology. The nuclei were stained with DAPI shown in blue and the F-
actin filaments were stained with Alexa Fluor® 594 Phalloidin. The overlapping of the 
blue and red and dispersion by the fibers causes some of the cells to be seem pink in color. 
Images captured at 10X magnification. 
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Figure 3.10 A panorama of premalignant cell line, MCF10ANeoT, on bare PCL scaffold 
with aligned morphology. The nuclei were stained with DAPI shown in blue and the F-
actin filaments were stained with Alexa Fluor® 594 Phalloidin. The overlapping of the 
blue and red and dispersion by the fibers causes some of the cells to be seem pink in color. 
Images captured at 10X magnification. 
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Figure 3.11 A panorama of the ductal adenocarcinoma cell line, MCF7, on bare PCL 
scaffold with honeycomb morphology. The nuclei were stained with DAPI shown in blue 
and the F-actin filaments were stained with Alexa Fluor® 594 Phalloidin. The overlapping 
of the blue and red and dispersion by the fibers causes some of the cells to be seem pink in 
color. Images captured at 10X magnification. 
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Figure 3.12 A panorama of the triple negative adenocarcinoma cell line, MDA-MB-231 on 
ManCou-H containing PCL fibers with an aligned morphology. The F-actin filaments were 
stained with Alexa Fluor® 594 Phalloidin shown in red, the ManCou-H probe is shown in 
blue. The overlapping of the blue and red and dispersion by the fibers causes some of the 




Figure 3.13 Phenotypes of the cells on scaffolds used to define cell behavior on the different 
morphologies of the scaffold. The phase images show the fibers and the overlaid 
fluorescent images show the alignment of nucleus against the orientation of the fibers. A) 
Aligned and elongated cells infiltrating into the scaffold. B) Clumped cells on scaffolds C) 
Cells aligning along the alignment of the scaffold D) The cells infiltrating through the 







Figure 3.14 Fluorescent microscope images of  Human Dermal Fibroblasts (HDFa) on 
different morphologies of B) PCL scaffold with and A) without ManCou-H probe on days 
1, 2 and 3. A) the nuclei were stained with DAPI (blue)  B) the probe is in blue and the F-
actin filaments were stained with Alexa Fluor® 594 Phalloidin (red). The overlapping of 
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the blue and red and dispersion by the fibers causes some of the cells to be seem pink in 
color. Images captured at 10X magnification. 
3.5.1.1 HDFa on Bare Scaffolds 
The adult human dermal fibroblasts shown in figure 3.14A, maintained an 
elongated morphology despite the scaffold topography.  
On non-probe containing fiber scaffolds the HDFa’s had little to no cellular 
orientation on any morphology on any day. The mesh fiber scaffolds had cell 
clumping in specific regions on all days and scaffold infiltration increased from day 
1 to day 3. On the aligned scaffolds the cells showed much less clumping on all 
days compared to the mesh although they had substantially infiltrated the scaffold 
on day 1 and continued to grow within the fibers through days 2 and 3. Cells on 
the honeycomb structure showed almost no clumping on day 1 but rather appeared 
to be spread out across the scaffold with some infiltration and some cellular 
orientation. By day 2 the cells began clumping in the porous regions of the scaffold 
with even more infiltration. Definitive cellular orientation is visible on day 3 as well 
as significant infiltration into the scaffold. 
3.5.1.2 HDFa on ManCou-H Containing Scaffolds 
The ManCou-H containing scaffolds (figure 3.14 B) behaved similarly to the 
non-probe containing scaffolds in the case of the mesh morphology. The cells are 
clumped with no cellular orientation and increasing infiltration from day 1 to day 3. 
The cells on the mesh scaffolding look to be interacting with the fructose mimic but 
not actively metabolizing it. Cellular orientation on the ManCou-H containing 
aligned fibers matched that of the fibers on all days. Scaffold infiltration is high on 
day 1 decreasing on day 2 then increasing again by day 3. Cells appear spread 
out with almost no clumping on all days. Again, probe can be seen in the vicinity 
of the cells, but they do not appear to be taking them up. The cellular orientation 
on the honeycomb structures is visible on day 1, ManCou-H appears to be taken 
up by the fibroblasts on this day. The HDFa cells infiltrate the scaffold and maintain 




Figure 3.15 Fluorescent microscope images of healthy breast epithelium (184B5) on 
different morphologies of B) PCL scaffold with and A) without ManCou-H probe on days 
1, 2 and 3. A) the nuclei were stained with DAPI (blue)  B) the probe is in blue and the F-
actin filaments were stained with Alexa Fluor® 594 Phalloidin (red). The overlapping of 
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the blue and red and dispersion by the fibers causes some of the cells to be seem pink in 
color. Images captured at 10X magnification. 
3.5.2.1 184B5 on Bare Scaffolds 
Figure 3.15A show images representative of the cell-cell and cell-scaffolds 
interactions of healthy breast epithelium, 184B5, on bare and ManCou-H 
containing scaffolds, respectively.  
 On the bare scaffolds the cells appeared to migrate and infiltrate all the 
scaffolds on day 1. Cells on mesh scaffolds appeared rounder and flatter on all 
days compared to more elongated and aligned morphologies on the honeycomb 
and aligned scaffolds. Infiltration of aligned and honeycomb scaffolds is at its 
highest on days 2 and 3. Little infiltration can be seen on the mesh scaffolds on all 
days. Clumping can be seen on day 3 among all scaffolds. 
3.5.2.2 184b5 on ManCou-H Containing Scaffolds  
 Similar cell-cell and cell-scaffold interactions were observed on the 
ManCou-H containing scaffolds on day 1 (figure 3.15B). Clumping on the aligned 
and honeycomb scaffolds can be seen on day 2 and excessive clumping was 
exhibited on day 3 of the aligned scaffolds. The mesh fibers continued to exhibit 
round and flat cells but the elongated morphology of the cells on the aligned and 





Figure 3.16 Fluorescent microscope images of Premalignant cells (MCF10AneoT) on 
different morphologies of B) PCL scaffold with and A) without ManCou-H probe on days 
1, 2 and 3. A) the nuclei were stained with DAPI (blue)  B) the probe is in blue and the F-
actin filaments were stained with Alexa Fluor® 594 Phalloidin (red). The overlapping of 
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the blue and red and dispersion by the fibers causes some of the cells to be seem pink in 
color. Images captured at 10X magnification. 
3.5.3.1 MCF10AneoT on Bare Scaffolds 
The analysis of the cell-scaffold interaction of the premalignant cell line, 
MCF10AneoT, can be seen in figure 3.16A on bare scaffolds and ManCou-H 
containing scaffolds.  
The cells on the bare scaffolds tended to clump together on all the 
morphologies on all the days. Cells appeared to clump in specific regions and 
maintained no cellular orientation on the mesh scaffolds. The aligned scaffolds 
exhibited cells which were spread across the scaffold with minimal alignment on 
days 1 and 2 then tended to clump on day 3. The cells on the honeycomb structure 
were able to infiltrate inside the different layers on day 1. This behavior could also 
be seen on day 2 in addition to some clumping. The cells again spread out by day 
3 and continued to infiltrate the scaffold compared to days 1 and 2. 
3.5.3.2 MCF10AneoT on ManCou-H Containing Scaffolds 
The ManCou-H containing scaffold, figure 3.16B resulted in clumping on 
day 1 of the mesh scaffolds on days 2 and 3 the cells appeared to spread out and 
migrate to distant areas on the scaffold while showing rounded and flattened 
morphologies. Clumping was observed on day 2 on the aligned and honeycomb 
scaffolds. Probe uptake can be seen on days 1 and 2 of the mesh and aligned 
scaffolds and day 2 and 3 on the honeycomb fibers. Uptake was also seen on day 
3 of the aligned scaffolds but to a lower extent. The mesh scaffolds showed cells 
which appeared to have a more spread out morphology among all days. Cells on 
aligned fibers aligned to the fibers to some extent on days 1 and 2 but became 
rounder by day 3. The honeycomb structures had cells which appeared both 





Figure 3.17 Fluorescent microscope images of Adenocarcinoma cells (MCF7) on different 
morphologies of B) PCL scaffold with and A) without ManCou-H probe on days 1, 2 and 
3. A) the nuclei were stained with DAPI (blue)  B) the probe is in blue and the F-actin 
filaments were stained with Alexa Fluor® 594 Phalloidin (red). The overlapping of the 
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blue and red and dispersion by the fibers causes some of the cells to be seem pink in color. 
Images captured at 10X magnification. 
3.5.4.1 MCF7 on Bare Scaffolds 
The behavior changes of the adenocarcinoma cell line, MCF7, due to the 
various morphologies as well as presence or absence of ManCou-H probe was 
qualitatively analyzed by staining the nucleus of cells on bare fibers and the 
cytoskeleton of all cells using immunofluorescent staining as was previously 
described. 
Figure 3.17A illustrates the PCL fibers, these showed cells clumping on day 1 
among all three morphologies but most extensive on the aligned scaffolds. The 
scaffolds with the mesh morphology showed cells on days 2 and 3 which were 
spread out and appeared to have infiltrated the scaffold, this made imaging difficult. 
The aligned scaffolds also showed cells spread out on days 2 and 3 however these 
cells showed an elongated morphology and were oriented along the direction of 
alignment of the fibers. The honeycomb scaffolds had a lot of cell clumping within 
the pores of the honeycomb and a very low concentration of cells on the boundary 
of the pores on day 2. On day 3 the cells on the honeycomb scaffold infiltrated the 
lower layers of the fibers and were present in between the fibers, this can be seen 
by the blurred regions between the fibers. Based on their distribution, morphology 
and orientation it appears the cells responded to the nano topographical cues 
provided by the different morphologies of each scaffold.  
3.5.4.2 MCF7 on ManCou-H Containing Scaffolds 
Similar trends can be deduced on the ManCou-H containing fibers in figure 
3.17B. Probe uptake was observed on all days of the mesh and aligned scaffolds. 
Cells remained spread out with no clumping on any scaffold on any day. The mesh 
fibers had rounded cells whereas the aligned fibers had cells which aligned with 
the scaffold. The honeycomb scaffold showed no uptake of probe and cells varied 




Figure 3.18 Fluorescent microscope images of triple negative adenocarcinoma (MDA-MB-
231) on different morphologies of PCL scaffold with and without ManCou-H probe on 
days 1, 2 and 3. On the left the nuclei were stained with DAPI (blue) on the right the probe 
is in blue and the F-actin filaments were stained with Alexa Fluor® 594 Phalloidin (red). 
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The overlapping of the blue and red and dispersion by the fibers causes some of the cells 
to be seem pink in color. Images captured at 10X magnification. 
3.5.5.1 MDA-MB-231 on Bare Scaffolds 
Again, using immunofluorescent staining, the interaction between MDA-
MB-231 cells and the bare scaffolds of different morphology were characterized 
(figure 3.18A).  
 On the mesh scaffolds the cells were distributed throughout without any 
logical orientation on days 1, 2 and 3. The cells on the bare aligned morphology 
lacked alignment on day 1 but were spread out across the sample, exhibiting little 
clumping. The cells on day 2 began to elongate and orient along the direction of 
fiber alignment. Cell infiltration into the different layers of the scaffolds can be 
deduced on day 3 by the blurred background. The bare honeycomb scaffolds 
exhibited little cellular alignment on day 1, but this was improved on day 2. By the 
third day in culture the cells infiltrated the scaffolds and attached to the walls of the 
honeycomb pores rather than the underlying layers of the fibers. Surprisingly, none 
of the morphologies seemed to promote clumping together of cells. 
3.5.5.2 MDA-MB-231 on ManCou-H Containing Scaffolds 
 On the ManCou-H containing scaffolds, figure 3.18B, the triple negative 
adenocarcinoma (MDA-MB-231) remained fairly spread out along the scaffold, 
only showing slight clumping on day 1 of the honeycomb scaffold. Probe uptake 
can be seen on day 2 of the mesh scaffolds. The cells appear to have detached 
from the aligned scaffolds on day 2 otherwise maintaining an elongated 
morphology oriented along and infiltrated within the scaffold. The mesh scaffolds 
exhibited rounded cells on day 1 and 2 but elongated unoriented cells on day 3. 
The honeycomb fibers have cells oriented along the fibers with cells exhibiting both 
elongated and somewhat rounded cells. 
3.6 Cell alignment  
3.6.1 Cell Alignment on Bare PCL scaffolds 
 The deviation of the fibroblasts on the scaffolds of all morphologies was as 
expected (figure 3.19A), a high deviation in orientation among the mesh scaffolds 
and more alignment, less deviation on the honeycomb and aligned morphologies. 
This trend was seen for days 1 and 2 however alignment on the mesh scaffolds on 
day 3 appears to be nearly equivalent to that of the honeycomb and aligned 
scaffolds, this is likely due to an error in segmentation. The healthy breast 
epithelium showed the lowest deviation among the honeycomb samples across all 
days with the mesh and aligned scaffold showing similar behavior (figure 3.19B). 
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Looking at the premalignant cell line the orientation deviation among the cells 
appears to be uniform among all samples except the mesh scaffolds on day 2 
which only shows one cell and resulting in a deviation in orientation from other cell 
lines of 0 (figure 3.19C). The adenocarcinoma shows similar trends with the lower 
deviation in cell orientation among cells on aligned and honeycomb structures 
(figure 3.19D). MDA-MB-231 appears to be quite variable, showing better 
alignment on the honeycomb structure on day 1 and aligned on day 2 and 3 (figure 
3.19E). Additional segmentation methods may need to be implemented in order to 
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Figure 3.19 Cell orientation deviation of all cell lines on all bare morphologies for days 1. 
2 and 3. Results were obtained by averaging the directional deviation between cells given 
by two different segmentation methods, watershed and Otsu thresholding. The y axis 
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3.6.2 Cell Alignment on ManCou-H Containing PCL scaffolds 
 Orientation deviation among the HDFa cell line was minimized on days 2 
and 3 on the aligned fibers (figure 3.20A). The honeycomb structures showed the 
least deviation on day 1 but the highest deviation on day 3. These results are nearly 
opposite to those shown by 184B5 which had the least deviation among the mesh 
scaffolds on days 1 and 2, the highest deviation of the honeycomb structures on 
days 1 and 2 and the lowest deviation on day 3 (figure 3.20B). The aligned 
scaffolds showed the highest deviation on day 3. For the premalignant cell line, the 
aligned scaffolds exhibited slightly less deviation among cell orientation, but 
deviation is very similar among all morphologies (figure 3.20C). The 
adenocarcinoma behaved as would be expected, showing the lowest deviation 
among the cells seeded in the aligned fibers followed by the cells on honeycomb 
fibers and the highest deviation on the mesh scaffolds on all days (figure 3.20D). 
Like the bare scaffolds the MDA-MB-231 behaved variably among all scaffolds, 
the aligned showed the lowest deviation on days 1 and 3 (figure 3.20E). Mesh 










































Figure 3.20 Cell orientation deviation of all cell lines on all ManCou-H containing 
morphologies for days 1. 2 and 3. Results were obtained by averaging the directional 
deviation between cells given by two different segmentation methods, watershed and Otsu 

























































3.7 Cell Viability 
3.7.1 Cell Viability on Bare Scaffolds 
The cell viability of each cell line on the scaffolds at time points 1, 2 and 3 
days was characterized by the reduction of resazurin to resorufin.  
On the bare PCL scaffolds, the human dermal fibroblasts exhibited a 
significant preference towards the mesh scaffolds peaking at day 1 then appearing 
to have a lower metabolic activity on day 2 before increasing again on day 3 (figure 
3.21A). These cells otherwise showed an increase in cell number among all other 
morphologies among all days. The difference in increased cell number with each 
day on aligned morphology was non-significant across all the days. The healthy 
breast epithelium showed an increase in cell number across all morphologies of 
the scaffolds on all the days (figure 3.21B). The difference in increased cell number 
with each day on aligned and honeycomb morphologies was non-significant across 
all the days. Scaffolds also demonstrated a significant increase in cell number 
among the adenocarcinoma cell line, MCF7, could be seen across all 
morphologies of the scaffold on all days (figure 3.21D). Day 3 showed a lower 
relative number of viable cells on the positive control when compared to the bare 
PCL morphologies. The difference in increased cell number with each day on 
positive control was non-significant across all the days. MDA-MB-231 cells 
exhibited a statistically significant increase in cell viability over all the days on all 
the samples (figure 3.21E). However, the positive control was the most favorable 
substrate for the triple negative cell line when compared to the other morphologies. 
This is likely due to the stiffness of the positive control, a tissue culture plate, ~10 
GPa, which plays a major role in cellular viability as shown by Mah and colleagues 
[53]. MCF10AneoT showed less uniform cell viability when compared to the 
viabilities of MDA-MB-231 and MCF7 cell lines on all morphologies (figure 3.21C). 
A more pronounced increase in cell number is seen from day 1 to day 2 on the 
mesh and aligned scaffolds. However, only an increase from day 2 to day 3 on the 
honeycomb scaffolds was shown to be significant. The positive control had non-
significant changes in cell viability among MCF10AneoT cells. The uniform 
behavior of the MDA-MB-231 and MCF7 cell lines is present among all 







































































































































Figure 3.21 Quantification of cell viability of bare scaffolds on days 1, 2 and 3 on different 
bare morphologies and cell lines. A) Cell viability of HDFa (Human Dermal Fibroblast) 
cells on different morphologies of the scaffold. B) Cell viability of 184B5 (healthy breast 
epithelium) cells on different morphologies of the scaffold. C) Cell viability of 
MCF10AneoT (premalignant) cells on different morphologies of the scaffold. D) Cell 
viability of MCF7 (adenocarcinoma) cells on different morphologies of the scaffold. Cells 
seeded on mesh scaffold had a significant increase in cell number till day 3. E) Cell viability 
of MDA-MB-231 (triple negative) cells on different morphologies of the scaffold. The cell 
number increased consistently on all scaffolds till day 3. The increase in cell viability was 
inconsistent across any morphology. Error bars represent the standard error of mean and 
statistical significance is indicated by p values (*p<0.05)   
3.7.2 Cell Viability on ManCou-H Containing Scaffolds 
On the ManCou-H containing PCL scaffolds, the HDFa again had a high 
cell number on day 1 which dropped on day 2 only to significantly increase again 
by day 3. The aligned fibers also showed a significant increase in cell viability 
among all days while the honeycomb structures only offered a significant increase 
between days 1 and 2 (figure 3.22A). The healthy breast epithelium showed an 
increase in cell number across all morphologies of the scaffolds on all the days 
(figure 3.22B) indicating a slight preference towards the aligned morphology but 
no significant changes were seen between any morphology or any day. The 
premalignant cell line showed a similar drop in viability on the mesh fibers from 
day 1 to day 2 as HDFa but to a lesser extent (figure 3.22C). A significant increase 
in cell viability across all days was seen on the aligned scaffolds. The mesh and 
honeycomb scaffolds had a significant increase in cell proliferation from days 2 to 
3 with what would appear to be an overall preference towards the honeycomb 





































structure. An increase among all morphologies over all 3 days can be seen in the 
adenocarcinoma cell line (figure 3.22D). This increase is significant for mesh and 
aligned scaffolds among all days but only for days 2 to 3 for the honeycomb 
morphology. The MCF7 appeared to prefer the mesh scaffolds to any other 
topography. An increase in MDA-MB-231 cell number can again be seen across 
all morphologies for the 3-day study. This increase is significant in the mesh 
scaffolds from day 1 to day 2 and from day 2 to day 3 on the honeycomb and 
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Figure 3.22 Quantification of cell viability of ManCou-H containing scaffolds on days 1, 
2 and 3 on different morphologies and cell lines. A) Cell viability of HDFa (Human Dermal 
Fibroblast) cells on different morphologies of the scaffold. B) Cell viability of 184B5 
(healthy breast epithelium) cells on different morphologies of the scaffold. C) Cell viability 
of MCF10AneoT (premalignant) cells on different morphologies of the scaffold. D) Cell 
viability of MCF7 (adenocarcinoma) cells on different morphologies of the scaffold. Cells 
seeded on mesh scaffold had a significant increase in cell number till day 3. E) Cell viability 
of MDA-MB-231 (triple negative) cells on different morphologies of the scaffold. The cell 
number increased consistently on all scaffolds till day 3. The increase in cell viability was 
inconsistent across any morphology. Error bars represent the standard error of mean and 
statistical significance is indicated by p values (*p<0.05)   
  































Topographical features and mechanical properties of the scaffolds were 
shown to influence the cell viability, cell-cell interaction and cell-scaffolds behavior. 
The adenocarcinoma, MCF7, cells proliferated well in all tested without much 
preference towards any particular topographical morphology. These findings are 
supported by the work of Chaudhuri et al. on the inhibition of Rho-ROCK-Myosin 
signaling in malignant cells leading to the proliferation of adenocarcinoma 
irrespective of the topography [23]. The cells did tend to prefer elastomeric 
scaffolds with low Young’s modulus and stiffness such as the mesh scaffolds over 
scaffolds with higher Young’s modulus and stiffness like the honeycomb and 
positive control. This agrees with several experimental investigations on MCF7 
including Li et. al on the mechanical properties of breast cancer cells through 
atomic force microscopic measurements and [54] and durotaxis studies performed 
by Cavo et. al [55].  
Alternatively, the triple-negative cell line tended to thrive on scaffolds with a 
stiffer matrix, this was expected due to the regulation of the YAP (Yes associated 
protein)/TAZ (transcriptional coactivator with PDZ-binding motif) followed by the 
activation of the Hippo cascade [56]. Topotactic and durotactic gradients guided 
the cellular alignment and infiltration on the honeycomb and aligned scaffolds 
which demonstrated extensive cellular infiltration as well as alignment. Lin et. al 
reported the stiffness of scaffolds positively enhances the migration potential of 
metastatic cells [57] and can drive tumor progression through a TWIST1-G3BP2 
mechanotransduction pathway [58]. The premalignant cells preferred the aligned 
scaffolds as they appeared to allow the cells to infiltrate and orient along the fibers. 
The aligned fibers provide topographical cues which aid in the cell spreading due 
to migration and can also impact tumor progression and metastasis [59].  
A certain amount of cell clumping was reported on all morphologies, this is 
in direct correlation of the metastatic potential of the cells. The metastatic potential 
of the cells indicates the clumped cells form protrusions followed shortly after by 
invasion [60, 61]. Observations made by Rubashkin et. al are consistent with 
increased viability and spreading of premalignant cells in stiffer scaffolds [62].  
Additionally, there did not appear to be much preferential difference in cell 
attachment, migration or proliferation between ManCou-H and non ManCou-H 
containing scaffolds. With the lack of nutrition offered by the fructose mimic it was 
expected that the cancerous cell lines would take up the probe via GLUT5 and die 
off. Alterations in this expectation could be due to the minimal amount of probe 
released in such a short time as shown by the degradation studies. The optimal 
concentration of ManCou-H within the scaffold may yet need to be determined.  
 For these reasons, it can be concluded that the cells respond to changes 
in scaffolds topography and mechanical properties based on the stage of cancer. 
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This indicates an in vitro tumor model which takes topotaxis and durotaxis into 
account would be suitable. Such a scaffold can provide the ideal platform for 
studying breast cancer metastasis or for localized therapy to inhibit the growth of 
metastatic cells. The efficient electrospun scaffold design also allows the scaffold 
system to be easily adapted for the study and treatment of other cancers through 




Different topotaxic and durotaxic features can be incorporated into 3D 
scaffolds via Polycaprolactone (PCL) electrospinning. These scaffolds have been 
shown to have similar surface chemistry yet when cancer cell lines of various 
malignancies were seeded behavior changes were apparent. Adenocarcinoma, 
triple negative, and premalignant breast cancer cell lines were seeded on 
nanofiber scaffolds of different morphologies in the presence and absence of 
fluorescent fructose mimics, ManCou-H. Using healthy breast epithelium and 
human dermal fibroblasts as controls, the cell-cell and cell-scaffold interactions 
were qualitatively analyzed using immunofluorescent staining and quantitatively 
analyzed for their cell viability over a period of 3 days.  
Human dermal fibroblasts proliferated more highly on mesh scaffolds 
followed closely by the positive control, both which exhibited a low elastic modulus. 
This was the case in the presence and absence of the ManCou-H probe. Cell 
alignment to the scaffold appeared to be more prevalent in the fibroblasts 
compared to other cell lines. Cells showed favorable alignment along these 
scaffolds. The adenocarcinoma cells also proliferated more highly on mesh 
scaffolds which exhibited a low elastic modulus similar to the HDFa.  
Healthy breast epithelium showed high variability, not seeming to prefer any 
one morphology on the bare fibers yet showing preference to the higher stiffness 
of the aligned and honeycomb structures. Despite these preferences the cells still 
appeared to have little alignment due to excessive clumping. The premalignant cell 
line preferred a more aligned morphology which had a high stiffness and more 
contact guidance when on PCL scaffolds without the ManCou-H. In the presence 
of ManCou-H this preference shifted more towards the honeycomb morphology 
which exhibited slightly less contact guidance. 
For PCL fibers which did not contain ManCou-H the triple negative cell line 
appeared to exhibit a slight preference to the honeycomb scaffolds with higher and 
strength as indicated by the cell viability as well as the immunofluorescent staining. 
In the presence of the ManCou-H, MDA-MB-231 appeared to shift its preference 
to the aligned morphology with the mesh and honeycomb not far behind. 
It was found that these scaffolds were able to mimic the mechanical and 
topographical tumor microenvironment by providing biophysical signals for 
topotaxis and durotaxis. These scaffolds were also able to provide information on 
the molecular uptake behavior of cells on various topographies. Changes in uptake 
altered the cell-cell and cell-scaffold interactions on similar topographies.  
It was also noted that the cancerous cell lines aligned more readily with the 
aligned scaffolds by day 3 on the bare PCL scaffolds, when compared to the non-
cancerous controls. This trend was not the same in the presence of the ManCou-
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H probe. The cancerous cell lines still showed a high alignment to the aligned 
scaffolds on day 3 but to a much smaller capacity. The MCF10ANeot showed 
similar deviation among all scaffolds. Furthermore, the HDFa exhibited high 
alignment on day 3 of the aligned scaffolds in the presence of the probe compared 
to the absence.   
These differential preferences towards topographical features indicate not only 
the benefit of using nanofiber scaffolds as platforms to model breast cancer but 
also the feasibility to design a nanofiber scaffold capable of attracting and trapping 
metastasizing cancer cells. Further studies will also be done to optimize the probe 
concentration within the scaffolds to offer a better understanding for the slow 
release of drugs or chemokines from PCL platforms. 
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5 Future Work 
Protein analysis through western blot would indicate what is happening within 
the cell with regards to upregulation and downregulation of specific pathways. 
Further investigation into preferences of different cancer cell lines such as small 
cell carcinoma, and kidney cancer would allow for potential expansion into 
relevance in all cancers. All of this research is currently underway to potentially 
lead to an engineered scaffold with controllable stiffness, structure and shape, in 
order to combat cancerous cells within the body as a cancer trap or outside of the 
body as a research platform for multiple types of cancer. 
Based on the response observed for cancer cells on scaffolds with the 
fructose-like molecular probe, the concentration, availability and the time of cell 
interaction with the probe should be optimized. Since there is also a cell-line 
dependent preference towards scaffolds, the probe optimization will also need to 
incorporate scaffold morphology. Future studies will include direct comparison with 





Figure 6.1 Fluorescent microscope images of human dermal fibroblasts (HDFa) on 
different morphologies of the PCL scaffold with and without ManCou-H probe on days 1, 
2 and 3. In A) the nuclei were stained with DAPI (blue) in B) the probe is in blue and the 
F-actin filaments were stained with Alexa Fluor® 594 Phalloidin (red). The images were 
overlaid with the phase contrast image to provide additional information about the scaffold 
morphology. The overlapping of the blue and red and dispersion by the fibers causes some 
of the cells to be seen pink in color. Images captured at 10X magnification. 
 
Figure 6.2 Fluorescent microscope images of healthy breast epithelium (184b5) on 
different morphologies of the PCL scaffold with and without ManCou-H probe on days 1, 
2 and 3. In A) the nuclei were stained with DAPI (blue) in B) the probe is in blue and the 
F-actin filaments were stained with Alexa Fluor® 594 Phalloidin (red).  The images were 
overlaid with the phase contrast image to provide additional information about the scaffold 
morphology. The overlapping of the blue and red and dispersion by the fibers causes some 
of the cells to be seen pink in color. Images captured at 10X magnification. 
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Figure 6.3 Fluorescent microscope images of premalignant breast cancer cells 
(MCF10AneoT) on different morphologies of the PCL scaffold with and without ManCou-
H probe on days 1, 2 and 3. In A) the nuclei were stained with DAPI (blue) in B) the probe 
is in blue and the F-actin filaments were stained with Alexa Fluor® 594 Phalloidin (red). 
The images were overlaid with the phase contrast image to provide additional information 
about the scaffold morphology. The overlapping of the blue and red and dispersion by the 




Figure 6.4 Fluorescent microscope images of adenocarcinoma cells (MCF7) on different 
morphologies of the PCL scaffold with and without ManCou-H probe on days 1, 2 and 3. 
In A) the nuclei were stained with DAPI (blue) in B) the probe is in blue and the F-actin 
filaments were stained with Alexa Fluor® 594 Phalloidin (red). The images were overlaid 
with the phase contrast image to provide additional information about the scaffold 
morphology. The overlapping of the blue and red and dispersion by the fibers causes some 
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Figure 6.5 Fluorescent microscope images of triple negative adenocarcinoma cells (MDA-
MB-231) on different morphologies of the PCL scaffold with and without ManCou-H 
probe on days 1, 2 and 3. In A) the nuclei were stained with DAPI (blue) in B) the probe 
is in blue and the F-actin filaments were stained with Alexa Fluor® 594 Phalloidin (red).  
The images were overlaid with the phase contrast image to provide additional information 
about the scaffold morphology. The overlapping of the blue and red and dispersion by the 
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